Aim immunotech provides third quarter 2020 business update

Ocala, fla., nov. 13, 2020 (globe newswire) -- aim immunotech inc. (nyse american: aim), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided a business update for the third quarter ended september 30, 2020.

AIM Ratings Summary

AIM Quant Ranking